Reporting owner · CIK 0001724190

Quinn William P.

SEC Form 4 history for the last 180 days across 1 company, 4 transactions and 1 filing.

PRES, CCPresident, CEO and CFOBolt Biotherapeutics, Inc.
Open-market transaction mix25% buys1 buy · 3 sales

Period: Last 180 days

Trade dates in this period: Jun 5, 2026 – Sep 18, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings1Form 4 records
Buying$2.47k1 purchase
Selling$58.4k3 sales
Net value−$55.9kBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Quinn William P. transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
BOLTBolt Biotherapeutics, Inc.
President · CC
PRES, CC
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$29.6kView disclosure →
BOLTBolt Biotherapeutics, Inc.
President · CC
PRES, CC
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$21.7kView disclosure →
BOLTBolt Biotherapeutics, Inc.
President · CC
PRES, CC
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$7.13kView disclosure →
BOLTBolt Biotherapeutics, Inc.
President · CC
PRES, CC
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
SEC filing ↗
$2.47kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a sale at Bolt Biotherapeutics, Inc. on Sep 18, 2026 valued at $29,554.80.

Review SEC filing
Latest buy

The insider reported a buy at Bolt Biotherapeutics, Inc. on Jun 5, 2026 valued at $2,469.01.

Review SEC filing

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Jun 202610$2,469.01$0+$2,469.01
Sep 202603$0$58,402.16−$58,402.16

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$15.2k
Median P/S size$14.4k
Direct4
Indirect0
Sep 18, 2026sale

Associated companies

Counts cover all available history, including outside the summary period

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

4 observations · Jun 5, 2026 – Sep 18, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 18, 202625,384 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Jun 5, 20262,950Sep 21, 2026View transaction
Sep 16, 202641,061Sep 21, 2026View transaction
Sep 17, 202634,516Sep 21, 2026View transaction
Sep 18, 202625,384Sep 21, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Quinn William P. Insider Activity FAQ

SEC Form 4 context

Who is Quinn William P.?

Quinn William P. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001724190.

Which companies has Quinn William P. reported transactions for?

Bolt Biotherapeutics, Inc.

When was Quinn William P.'s latest insider buy?

The insider reported a buy at Bolt Biotherapeutics, Inc. on Jun 5, 2026 valued at $2,469.01.

When was Quinn William P.'s latest insider sale?

The insider reported a sale at Bolt Biotherapeutics, Inc. on Sep 18, 2026 valued at $29,554.80.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.